زراعة نخاع العظم من متبرع ذي صلة في إسبانيا

• زراعة النخاع العظمي من متبرع قريب

POST-TRANSPLANTATION FOLLOW-UP Weekly consultation during a period of 100 days (15 consultations) Weekly analytical (15 Analytics) 15 Cyclosporin levels and 15 CMV PCR Accompanying diet for 35 days

• 35 ايام في المستشفى

• لا يتم تضمين النقل

When a related donor is available, the first priority is to confirm that allogeneic transplantation is truly indicated, assess the current disease status, and establish whether the family donor is sufficiently compatible. I recommend evaluation with Prof. Luis Madero at Hospital Universitario Quirónsalud Madrid, where the case can be reviewed within a dedicated pediatric hemato-oncology pathway.

Why Prof. Luis Madero

• Head of Pediatric Hemato-Oncology at Hospital Universitario Quirónsalud Madrid.
• Head of Pediatric Hemato-Oncology and Hematopoietic Transplantation at Hospital Niño Jesús in Madrid.
• Professor of Pediatrics at Universidad Autónoma de Madrid.
• Author of more than 200 international scientific publications, with extensive experience in childhood leukemia, lymphoma, bone marrow disorders and hematopoietic transplantation.

Why Quirónsalud Madrid

The hospital has a dedicated Pediatric Hemato-Oncology Service and can coordinate hematology, pediatrics, intensive care, transfusion medicine, laboratory diagnostics and specialist support within the same hospital.

For transplantation, the team evaluates the patient and potential related donor together, including HLA compatibility, infectious screening and organ-function testing before treatment is approved.

Evaluation and treatment package

• Consultation with Prof. Luis Madero
• Review of bone marrow biopsy, pathology, cytogenetics and molecular studies.
• Complete blood count, biochemistry and coagulation profile.
• HLA typing of the patient and related donor.
• Donor medical assessment and infectious-disease screening.
• Cardiac, pulmonary, renal and liver assessment.
• Bone marrow examination if an updated evaluation is required.
• Conditioning chemotherapy.
• Collection of hematopoietic stem cells from the related donor.
• Allogeneic stem-cell infusion.
• Protective inpatient hospitalization during marrow recovery.
• Blood-product and anti-infective support.
• Prevention and monitoring of graft-versus-host disease.
• Early post-transplant follow-up.
• Complete pre-transplant patient and donor evaluation
• Related-donor allogeneic bone marrow/stem-cell transplantation

• منسق طبي خاص
• ترتيبات السفر الطبي - حجز تذاكر السفر الجوي وغرف الفنادق بأسعار خاصة للشركاء
• دعوة المريض أثناء السفر الطبي